Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Quantitative 1H NMR Metabolomics Reveal Distinct Metabolic Adaptations in Human Macrophages Following Differential Activation.

Fuchs AL, Schiller SM, Keegan WJ, Ammons MCB, Eilers B, Tripet B, Copié V.

Metabolites. 2019 Oct 24;9(11). pii: E248. doi: 10.3390/metabo9110248.

2.

Metabolic immunomodulation of macrophage functional plasticity in nonhealing wounds.

Anders CB, Lawton TMW, Ammons MCB.

Curr Opin Infect Dis. 2019 Jun;32(3):204-209. doi: 10.1097/QCO.0000000000000550.

PMID:
30950855
3.

Characterization of the antibacterial activity of Bald's eyesalve against drug resistant Staphylococcus aureus and Pseudomonas aeruginosa.

Fuchs AL, Weaver AJ Jr, Tripet BP, Ammons MCB, Teintze M, Copié V.

PLoS One. 2018 Nov 28;13(11):e0208108. doi: 10.1371/journal.pone.0208108. eCollection 2018.

4.

Biochemical association of metabolic profile and microbiome in chronic pressure ulcer wounds.

Ammons MC, Morrissey K, Tripet BP, Van Leuven JT, Han A, Lazarus GS, Zenilman JM, Stewart PS, James GA, Copié V.

PLoS One. 2015 May 15;10(5):e0126735. doi: 10.1371/journal.pone.0126735. eCollection 2015.

5.

Quantitative NMR metabolite profiling of methicillin-resistant and methicillin-susceptible Staphylococcus aureus discriminates between biofilm and planktonic phenotypes.

Ammons MC, Tripet BP, Carlson RP, Kirker KR, Gross MA, Stanisich JJ, Copié V.

J Proteome Res. 2014 Jun 6;13(6):2973-85. doi: 10.1021/pr500120c. Epub 2014 May 8.

6.

Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic.

Ammons MC, Copié V.

Biofouling. 2013;29(4):443-55. doi: 10.1080/08927014.2013.773317. Review.

7.

Anti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressings.

Ammons MC, Ward LS, James GA.

Int Wound J. 2011 Jun;8(3):268-73. doi: 10.1111/j.1742-481X.2011.00781.x. Epub 2011 Apr 1.

PMID:
21457463
8.

Combined treatment of Pseudomonas aeruginosa biofilm with lactoferrin and xylitol inhibits the ability of bacteria to respond to damage resulting from lactoferrin iron chelation.

Ammons MC, Ward LS, Dowd S, James GA.

Int J Antimicrob Agents. 2011 Apr;37(4):316-23. doi: 10.1016/j.ijantimicag.2010.12.019. Epub 2011 Mar 5.

PMID:
21377840
9.

Modulation of PLAGL2 transactivation by positive cofactor 2 (PC2), a component of the ARC/Mediator complex.

Wezensky SJ, Hanks TS, Wilkison MJ, Ammons MC, Siemsen DW, Gauss KA.

Gene. 2010 Feb 15;452(1):22-34. doi: 10.1016/j.gene.2009.12.003. Epub 2009 Dec 16.

10.

Anti-biofilm strategies and the need for innovations in wound care.

Ammons MC.

Recent Pat Antiinfect Drug Discov. 2010 Jan;5(1):10-7. Review.

PMID:
19807676
11.

In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol.

Ammons MC, Ward LS, Fisher ST, Wolcott RD, James GA.

Int J Antimicrob Agents. 2009 Mar;33(3):230-6. doi: 10.1016/j.ijantimicag.2008.08.013. Epub 2008 Nov 1.

PMID:
18977641
12.

Binding of pleomorphic adenoma gene-like 2 to the tumor necrosis factor (TNF)-alpha-responsive region of the NCF2 promoter regulates p67(phox) expression and NADPH oxidase activity.

Ammons MC, Siemsen DW, Nelson-Overton LK, Quinn MT, Gauss KA.

J Biol Chem. 2007 Jun 15;282(24):17941-52. Epub 2007 Apr 26. Erratum in: J Biol Chem. 2007 Jul 20;282(29):21572.

13.

The expanding role of NADPH oxidases in health and disease: no longer just agents of death and destruction.

Quinn MT, Ammons MC, Deleo FR.

Clin Sci (Lond). 2006 Jul;111(1):1-20. Review.

PMID:
16764554

Supplemental Content

Loading ...
Support Center